Sinovac Biotech Ltd.

SVA · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$1,270,131$4,278,124$11,608,855$1,041,008
Short-Term Investments$9,953,042$7,034,569$1,806,449$135,248
Receivables$450,722$609,489$952,402$253,487
Inventory$139,874$180,719$375,511$105,813
Other Curr. Assets$16,787$23,495$171,892$24,737
Total Curr. Assets$11,830,556$12,126,396$14,915,109$1,560,293
Property Plant & Equip (Net)$1,031,914$1,173,279$1,083,964$304,396
Goodwill$0$0$0$0
Intangibles$8,520$79,514$41,210$9,721
Long-Term Investments$684,285$661,440$655,835$7,109
Tax Assets$29,790$71,118$52,031$26,891
Other NC Assets$72,909$2,821$25-$7,084
Total NC Assets$1,827,418$1,988,172$1,833,065$341,033
Other Assets$0$0$0$0
Total Assets$13,657,974$14,114,568$16,748,174$1,901,326
Liabilities
Payables$17,291$19,825$58,590$30,543
Short-Term Debt$81,895$10,644$15,066$42,613
Tax Payable$41,258$256,640$1,302,090$42,130
Deferred Revenue$20,127$33,075$92,500$379,164
Other Curr. Liab.$987,333$1,587,254$1,625,657$363,408
Total Curr. Liab.$1,147,904$1,091,635$2,412,846$679,610
LT Debt$217,088$64,029$129,841$93,773
Deferred Rev, NC$6,065$4,477$4,870$4,229
Deferred Tax Liab, NC$263,711$241,526$324,164$2,724
Other NC Liab.$439$240$444$865
Total NC Liab.$487,303$310,272$459,319$101,591
Other Liabilities$0$0$0$0
Cap. Leases$45,077$58,509$122,850$89,005
Total Liabilities$1,635,207$1,401,907$2,872,165$781,201
Equity
Pref Stock$15$15$15$15
Common Stock$100$100$100$99
Retained Earnings$7,118,516$7,225,987$7,141,819$144,241
AOCI$1,049,529$1,154,737$1,644,919$70,302
Other Equity$541,258$540,582$540,582$531,815
Total Equity$8,709,418$8,921,421$9,327,435$746,472
Supplemental Information
Minority Interest$3,313,349$3,791,240$4,548,574$373,653
Total Liab. & Tot. Equity$13,657,974$14,114,568$16,748,174$1,901,326
Net Debt-$971,148-$4,203,451-$11,463,948-$904,622